PARSIPPANY, N.Y. – Ascensia Diabetes Care has received clearance from the U.S. Food and Drug Administration for the Contour Next One blood glucose monitoring system. “This is an innovative new option for people living with diabetes,” said Robert Schumm, head of Ascencia Diabetes Care U.S., in a statement. “The system combines the remarkable accuracy of the Contour Next One meter with the easy-to-use features of the Contour Diabetes app and is designed to provide insights that may help people manage their diabetes in a better way.” The system features a smartLIGHT that provides instant feedback on blood glucose results, reminders and alerts to help support better management of diabetes, and an electronic logbook to record meals, activities and medication. Users can set up an optional secure cloud-based account to manage and store their data, and have the ability to email PDF summary reports to their provider. The Contour Next One system will be available in the U.S. early next year.
You are here: / / Ascensia receives clearance for app-enabled blood glucose monitoring system